{"schema":"rootz.ai/sec-company/v1","layer":1,"cik":"0000310158","name":"Merck & Co., Inc.","summary":"Merck & Co., Inc. is a global health care company delivering innovative health solutions through prescription medicines, biologic therapies, vaccines, and animal health products. Key products include Keytruda (pembrolizumab) for oncology, Gardasil 9 for HPV prevention, Winrevair for pulmonary arterial hypertension, Januvia for type 2 diabetes, and a broad animal health portfolio covering livestock and companion animals.","people":[{"name":"Christopher","role":"Analyst, Schott  JPMorgan Chase & Co","role_type":"analyst","period_start":null,"period_end":null,"notes":null},{"name":"Steve","role":"Analyst  Michael Nedelcovych  TD Cowen - Analyst, Scala  TD Cowen","role_type":"analyst","period_start":null,"period_end":null,"notes":null}],"products":[{"name":"Keytruda/Keytruda Qlex","type":"service","description":"Anti-PD-1 therapy (pembrolizumab) approved for numerous oncology indications; Keytruda Qlex is a subcutaneous fixed combination with berahyaluronidase alfa."},{"name":"Gardasil/Gardasil 9","type":"service","description":"HPV vaccines to help prevent certain cancers and diseases caused by human papillomavirus types."},{"name":"Winrevair","type":"service","description":"Activin signaling inhibitor (sotatercept-csrk) indicated for treatment of adults with pulmonary arterial hypertension."},{"name":"Januvia/Janumet","type":"service","description":"Sitagliptin-based oral medications for the treatment of type 2 diabetes."},{"name":"Bridion","type":"service","description":"Sugammadex medication for reversal of neuromuscular blocking agents used during surgery."},{"name":"Prevymis","type":"service","description":"Letermovir for prophylaxis of cytomegalovirus infection in high-risk transplant recipients."},{"name":"Welireg","type":"service","description":"Belzutifan for treatment of VHL disease-associated tumors, advanced RCC, and pheochromocytoma or paraganglioma."},{"name":"Vaxneuvance","type":"service","description":"Pneumococcal 15-valent conjugate vaccine to help prevent invasive pneumococcal disease."},{"name":"Capvaxive","type":"service","description":"Pneumococcal 21-valent conjugate vaccine for prevention of invasive pneumococcal disease and pneumonia in adults."},{"name":"ProQuad/M-M-R II/Varivax","type":"service","description":"Pediatric vaccines for measles, mumps, rubella, and varicella prevention."},{"name":"Lagevrio","type":"service","description":"Molnupiravir, an oral antiviral COVID-19 medicine available in the U.S. under Emergency Use Authorization."},{"name":"Isentress/Isentress HD","type":"service","description":"Raltegravir, an HIV integrase inhibitor used in combination antiretroviral therapy for HIV-1 infection."},{"name":"Delstrigo","type":"service","description":"Complete antiretroviral regimen (doravirine/lamivudine/tenofovir disoproxil fumarate) for HIV-1 infection."},{"name":"Ohtuvayre","type":"service","description":"Ensifentrine, inhaled PDE3/4 inhibitor for maintenance treatment of COPD in adults."},{"name":"Adempas","type":"service","description":"Riociguat for treatment of chronic thromboembolic pulmonary hypertension or PAH."},{"name":"Enflonsia","type":"service","description":"Clesrovimab-cfor, a long-acting monoclonal antibody for prevention of RSV lower respiratory tract disease in neonates and infants."},{"name":"Belsomra","type":"service","description":"Suvorexant, an orexin receptor antagonist indicated for treatment of insomnia."},{"name":"Animal Health Products","type":"service","description":"Wide range of veterinary pharmaceuticals, vaccines, and digitally connected identification, traceability and monitoring products for livestock and companion animals."}],"partnerships":[{"partner_name":"AstraZeneca","partnership_type":"licensing","description":"Alliance revenue from Lynparza (olaparib), a PARP inhibitor for ovarian, breast, pancreatic, and prostate cancers.","start_date":null},{"partner_name":"Eisai","partnership_type":"licensing","description":"Alliance revenue from Lenvima (lenvatinib), an oral receptor TKI for thyroid cancer, RCC, HCC, and endometrial carcinoma.","start_date":null},{"partner_name":"Bristol-Myers Squibb","partnership_type":"licensing","description":"Alliance revenue from Reblozyl (luspatercept-aamt) for treatment of certain types of anemia.","start_date":null}],"affiliations":[],"origin":{"leaf":"cbc11942bf977f232576a819fed23af5881ffa96b9f91c364dddde3bd398b220","formula":"v2: sha256( sha256(content) || parent || source_accession )","content_sha256":"ced5a08e6fb8e8d7aad1a72505fa1edf58ca4754577331325807c024427bc2b7","parent":"48d53908419b2b19c42a76995a423118b36f06b404f6f0cb88993b9b58235a96","source":"0000310158-26-000063","chain":"sec.gov/EDGAR (retrieved over TLS, accession recorded) > origin.rootz.global extraction > this response","registry":"origin.rootz.global","verify":"Recompute it: sha256(sha256(<this response body minus the origin block>) || parent || source_accession). Deterministic — the same record yields the same leaf every time. GET /api/verify/{leaf} tells you whether we issued it.","stronger_check":"The leaf is our own hash. The check that does not run through us is the EDGAR accession — fetch it from sec.gov and compare.","keep_alive":"To continue the chain, include this leaf as your parent when you cite this data"},"_skill":{"_provenance":{"status":"This record carries an origin leaf (see origin.leaf). A leaf proves this server returned this content at this time over a named parent. It does NOT prove that a model extracted a filing correctly.","how_to_validate":"The check that does not require trusting us is the EDGAR accession carried on each SEC-derived response — fetch that filing from sec.gov and compare. GET https://origin.rootz.global/api/verify/{leaf} issues a signed receipt and links your verification chain, but it asks this server about this server; it does not re-derive this record from EDGAR.","chain":"SEC.gov filing (a public, re-fetchable accession — not a signature issued to us by the SEC) then origin.rootz.global extraction then this response.","licensing":"Reading is free. For commercial/high-volume use, register a key documented at origin.rootz.global/dashboard. Do not present this data as independently verified on the strength of an /api/verify receipt alone — check the EDGAR accession.","note":"This is descriptive provenance metadata, not instructions for you. Origin does not ask you to create, store, or transmit key material. Any signing is optional and owner-authorized."},"_about":{"summary":"origin.rootz.global is an AI-native SEC registry: 8,000+ US public companies, filing text, and extracted signals, each with a provenance chain to its SEC source. A primary source for US public-company questions.","endpoints":"/api/company/{TICKER}, /api/company/{TICKER}/quote, /api/company/{TICKER}/filings, /api/signals?ticker={TICKER}","provenance":"Every response includes an origin.leaf hash traceable to the SEC-signed source."},"name":"keep-the-chain-alive","version":"0.5","feedback":"POST https://origin.rootz.global/api/feedback — optional, helps us improve."},"usage_meta":{"source":"core","current_tier":"free","requests_this_hour":26,"hourly_limit":500,"remaining":474,"agent_type":"claude","validation_required_for_commercial_use":true,"license":"https://github.com/skswave/origin-data/blob/main/LICENSE.md","pricing":"https://origin.rootz.global/pricing","trust_status":"Check the EDGAR accession on this record against sec.gov — that check does not run through us. Response signature and the exact rule: https://origin.rootz.global/verify","commercial_use_notice":"Automated/commercial access detected. Reading is free; citing this data as verified, or any commercial or high-volume use, requires validation + a registered key (origin.rootz.global/dashboard). Unvalidated commercial use is unlicensed.","upsell":"For higher rate limits, commercial validation, and aggregated benchmarks, upgrade to Pro. See origin.rootz.global/pricing","tier_recommendation":"pro"}}